Liposomes in cancer therapy: how did we start and where are we now

MD Fulton, W Najahi-Missaoui - International Journal of Molecular …, 2023 - mdpi.com
Since their first discovery in the 1960s by Alec Bangham, liposomes have been shown to be
effective drug delivery systems for treating various cancers. Several liposome-based …

[HTML][HTML] Exercise as a prescription for patients with various diseases

X Luan, X Tian, H Zhang, R Huang, N Li, P Chen… - Journal of sport and …, 2019 - Elsevier
A growing understanding of the benefits of exercise over the past few decades has
prompted researchers to take an interest in the possibilities of exercise therapy. Because …

Breast cancer statistics, 2022

AN Giaquinto, H Sung, KD Miller… - CA: a cancer journal …, 2022 - Wiley Online Library
This article is the American Cancer Society's update on female breast cancer statistics in the
United States, including population‐based data on incidence, mortality, survival, and …

Cancer treatment and survivorship statistics, 2016

KD Miller, RL Siegel, CC Lin… - CA: a cancer journal …, 2016 - Wiley Online Library
The number of cancer survivors continues to increase because of both advances in early
detection and treatment and the aging and growth of the population. For the public health …

[HTML][HTML] A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer

CY Huang, DT Ju, CF Chang, PM Reddy… - Biomedicine, 2017 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer deaths worldwide, and this makes it an attractive
disease to review and possibly improve therapeutic treatment options. Surgery, radiation …

Yolk–shell structured Au nanostar@ metal–organic framework for synergistic chemo-photothermal therapy in the second near-infrared window

X Deng, S Liang, X Cai, S Huang, Z Cheng, Y Shi… - Nano …, 2019 - ACS Publications
Light-sensitive yolk–shell nanoparticles (YSNs) as remote-controlled and stimuli-responsive
theranostic platforms provide an attractive method for synergistic cancer therapy. Herein, a …

Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases

V Raman, N Van Dessel, CL Hall, VE Wetherby… - Nature …, 2021 - nature.com
Critical cancer pathways often cannot be targeted because of limited efficiency crossing cell
membranes. Here we report the development of a Salmonella-based intracellular delivery …

Glucocorticoids—all-rounders tackling the versatile players of the immune system

C Strehl, L Ehlers, T Gaber, F Buttgereit - Frontiers in immunology, 2019 - frontiersin.org
Glucocorticoids regulate fundamental processes of the human body and control cellular
functions such as cell metabolism, growth, differentiation, and apoptosis. Moreover …

[HTML][HTML] Circular RNA: a novel biomarker and therapeutic target for human cancers

B Lei, Z Tian, W Fan, B Ni - International journal of medical …, 2019 - ncbi.nlm.nih.gov
Circular (circ) RNAs, a newly recognized class of noncoding RNA, have been implicated in
the occurrence and development of several diseases, including neurological and …

Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy

D Cardinale, A Colombo, G Bacchiani, I Tedeschi… - Circulation, 2015 - Am Heart Assoc
Background—Three types of anthracycline-induced cardiotoxicities are currently
recognized: acute, early-onset chronic, and late-onset chronic. However, data supporting …